Breast cancer is the leading cause of death, especially for women in Indonesia. Compounds that are widely used for anticancer at present are organotin compounds, one of which is dithiocarbamate compounds, with several reports of antifungal, antibacterial, anticancer, anti-alkylation, and apoptosis-inducing activities of metal dithiocarbamate complexes and their mixed ligands. The purpose of this study was to determine the activity test of the synthetic compound Diphenyltin (IV) N-Benzylmethyldithiocarbamate Against Breast Cancer MCF-7 using the MTT Assay (Microculture Tetrazolium Technique) Assay and to determine the functional group and structure of the compound Dibutyltin (IV) N-Benzylmethylditiocarbamate, used Spectrophotometer test FTIR (Fourier Transformed Infrared) and FTNMR (Nuclear Magnetic Resonance). From this study, it was found that the synthetic compound Diphenyltin (IV) N-Benzylmethyldithiocarbamate is a very potent compound in inhibiting the development and growth of MCF-7 breast cancer cells, because the compound has an IC50 value that is smaller than 10 g/ml which is 69, 640ppm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.